title: Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
abstract: The antitumor activity of the antineoplastic agent, tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide), has previously been shown to require intracellular anabolism of the drug to a nicotinamide adenine dinucleotide (NAD) analog (2-beta-D-ribofuranosylthiazole-4-carboxamide adenine dinucleotide or "tiazofurin adenine dinucleotide"), which then acts as a potent inhibitor of the target enzyme inosine monophosphate (IMP) dehydrogenase. Inhibition of the latter enzyme in turn brings about a profound depletion of intracellular guanosine nucleotides essential for tumor cell growth and replication. In the present study, the cytotoxicity and metabolism of tiazofurin have been examined in six human lung cancer cell lines. At the pharmacologically attainable drug concentration of 100 microM, colony survival was less than 1.5% in three cell lines ("sensitive"), while survival in the remaining three was greater than 50% ("resistant"). The metabolism of tritiated tiazofurin was examined at concentrations ranging from 0.5 to 100 microM following both brief (6 h) and protracted (14 d) exposures. The sensitive lines accumulated concentrations of tiazofurin adenine dinucleotide that were approximately 10 times those achieved by the resistant lines at both time points. We also observed tendencies for the sensitive cell lines to exhibit: (a) higher specific activities of NAD pyrophosphorylase, the enzyme required for the synthesis of tiazofurin adenine dinucleotide, (b) significantly lower levels of a phosphodiesterase which degrades the latter dinucleotide, (c) greater inhibition of the target enzyme IMP dehydrogenase, and (d) greater depressions of guanosine nucleotide pools after drug treatment. By contrast, the basal levels of IMP dehydrogenase and purine nucleotides in these six lines did not correlate in any obvious way with their responsiveness or resistance. The accumulation and monophosphorylation of parent drug were also not prognostic variables. These studies thus suggest that the extent of accumulation of tiazofurin adenine dinucleotide, as regulated by its synthetic and degradative enzyme activities, is the single most predictive determinant of the responsiveness of cultured human lung tumor cells to tiazofurin.
authors.forename: D N
authors.initials: DN
authors.lastname: Carney
authors.forename: G S
authors.initials: GS
authors.lastname: Ahluwalia
authors.forename: H N
authors.initials: HN
authors.lastname: Jayaram
authors.forename: D A
authors.initials: DA
authors.lastname: Cooney
authors.forename: D G
authors.initials: DG
authors.lastname: Johns
mesh_terms: D000227:Adenine Nucleotides / Q000096:biosynthesis / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002460:Cell Line; D002478:Cells, Cultured; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D007168:IMP Dehydrogenase / Q000378:metabolism; D008175:Lung Neoplasms / Q000188:drug therapy*; D011685:Purine Nucleotides / Q000378:metabolism; D011742:Pyrimidine Nucleotides / Q000378:metabolism; D012254:Ribavirin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D012685:Sepharose; D014410:Tumor Stem Cell Assay
chemical_list: D000227:Adenine Nucleotides; D000970:Antineoplastic Agents; D011685:Purine Nucleotides; D011742:Pyrimidine Nucleotides; D012263:Ribonucleosides; D012254:Ribavirin; C038167:thiazole-4-carboxamide adenine dinucleotide; D012685:Sepharose; D007168:IMP Dehydrogenase; C033706:tiazofurin